Correlation between NLR and prognosis of concurrent chemoradiotherapy
10.11904/j.issn.1002-3070.2019.03.018
- VernacularTitle:NLR与肿瘤同步放化疗预后的相关性研究
- Author:
Yue FENG
1
;
Linan XING
;
Zhao WANG
;
Yunyan ZHANG
Author Information
1. 哈尔滨医科大学附属肿瘤医院(哈尔滨 150081
- Keywords:
NLR;
Concurrent chemoradiotherapy;
Prognosis
- From:
Practical Oncology Journal
2019;33(3):284-288
- CountryChina
- Language:Chinese
-
Abstract:
By now,the clinical methods of cancer treatment are mainly surgery,radiotherapy,chemotherapy,and traditional Chinese medicine methods. However,some tumors are concealed due to onset,initial diagnosis and treatment,which have entered the middle and late stage,lost the operation opportunity and impossible to pass accurate surgical staging by assessment of prognosis. Radi-cal concurrent chemoradiotherapy can be used for tumors that are inoperable and sensitive to radiation therapy. Therefore,it has be-come a hot spot to explore accurate and economic indicators to evaluate the prognosis of radiotherapy and chemotherapy. Neutrophil to lymphocyte ratio(NLR)refers to the ratio of neutrophils to lymphocytes in peripheral blood before treatment. As a general indicator of systemic inflammatory response,many studies have confirmed that the relationship between the efficacy of radiotherapy and chemother-apy for tumors provides a new way to evaluate the prognosis of tumors. This article briefly reviews the relationship between NLR and the prognosis of tumor-controlled radiotherapy and chemotherapy.
